APO RESEARCH · REPORT
Methotrexate
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Product & engineering
Understand the product.
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
Selected research
Market Structure
Global Methotrexate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
Read the full market overview
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
This report provides an overview of the global Methotrexate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Methotrexate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Methotrexate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Methotrexate market size, projected growth trends, production technologies, key applications, and end-use industries.
Methotrexate Segment by Company
Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Methotrexate Segment by Type
Methotrexate for Injection
Methotrexate Tablets
Methotrexate Segment by Application
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
Methotrexate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Methotrexate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Methotrexate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Methotrexate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Methotrexate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Methotrexate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Methotrexate for Injection
- Methotrexate Tablets
Applications
- Used for Cancers
- Used for Rheumatoid Arthritis
- Used for Other Diseases
Companies covered
- Teva Pharmaceutical Industries
- Qualitestrx (DAVA Pharmaceuticals)
- Pfizer (Hospira)
- Roxane Laboratories
- Sine
- Maoxiang
- LingNan Pharmaceutical
- Powerdone
- Huiyu
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Methotrexate Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Methotrexate Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Methotrexate Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Methotrexate Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Methotrexate Market Dynamics
- 2.1 Methotrexate Industry Trends
- 2.2 Methotrexate Industry Drivers
- 2.3 Methotrexate Industry Opportunities and Challenges
- 2.4 Methotrexate Industry Restraints
3 Methotrexate Market by Manufacturers
- 3.1 Global Methotrexate Revenue by Manufacturers (2021-2026)
- 3.2 Global Methotrexate Sales by Manufacturers (2021-2026)
- 3.3 Global Methotrexate Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Methotrexate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Methotrexate Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Methotrexate Manufacturers, Product Type & Application
- 3.7 Global Methotrexate Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Methotrexate Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Methotrexate Players Market Share by Revenue in 2025
- 3.8.3 2025 Methotrexate Tier 1, Tier 2, and Tier 3
4 Methotrexate Market by Type
- 4.1 Methotrexate Type Introduction
- 4.1.1 Methotrexate for Injection
- 4.1.2 Methotrexate Tablets
- 4.2 Global Methotrexate Sales by Type
- 4.2.1 Global Methotrexate Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Methotrexate Sales by Type (2021-2032)
- 4.2.3 Global Methotrexate Sales Market Share by Type (2021-2032)
- 4.3 Global Methotrexate Revenue by Type
- 4.3.1 Global Methotrexate Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Methotrexate Revenue by Type (2021-2032)
- 4.3.3 Global Methotrexate Revenue Market Share by Type (2021-2032)
5 Methotrexate Market by Application
- 5.1 Methotrexate Application Introduction
- 5.1.1 Used for Cancers
- 5.1.2 Used for Rheumatoid Arthritis
- 5.1.3 Used for Other Diseases
- 5.2 Global Methotrexate Sales by Application
- 5.2.1 Global Methotrexate Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Methotrexate Sales by Application (2021-2032)
- 5.2.3 Global Methotrexate Sales Market Share by Application (2021-2032)
- 5.3 Global Methotrexate Revenue by Application
- 5.3.1 Global Methotrexate Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Methotrexate Revenue by Application (2021-2032)
- 5.3.3 Global Methotrexate Revenue Market Share by Application (2021-2032)
6 Global Methotrexate Sales by Region
- 6.1 Global Methotrexate Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Methotrexate Sales by Region (2021-2032)
- 6.2.1 Global Methotrexate Sales by Region (2021-2026)
- 6.2.2 Global Methotrexate Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Methotrexate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Methotrexate Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Methotrexate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Methotrexate Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Methotrexate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Methotrexate Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Methotrexate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Methotrexate Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Methotrexate Revenue by Region
- 7.1 Global Methotrexate Revenue by Region
- 7.1.1 Global Methotrexate Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Methotrexate Revenue by Region (2021-2026)
- 7.1.3 Global Methotrexate Revenue by Region (2027-2032)
- 7.1.4 Global Methotrexate Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Methotrexate Revenue (2021-2032)
- 7.2.2 North America Methotrexate Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Methotrexate Revenue (2021-2032)
- 7.3.2 Europe Methotrexate Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Methotrexate Revenue (2021-2032)
- 7.4.2 Asia-Pacific Methotrexate Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Methotrexate Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Methotrexate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva Pharmaceutical Industries
- 8.1.1 Teva Pharmaceutical Industries Company Information
- 8.1.2 Teva Pharmaceutical Industries Business Overview
- 8.1.3 Teva Pharmaceutical Industries Methotrexate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Pharmaceutical Industries Methotrexate Product Portfolio
- 8.1.5 Teva Pharmaceutical Industries Recent Developments
- 8.2 Qualitestrx (DAVA Pharmaceuticals)
- 8.2.1 Qualitestrx (DAVA Pharmaceuticals) Company Information
- 8.2.2 Qualitestrx (DAVA Pharmaceuticals) Business Overview
- 8.2.3 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Product Portfolio
- 8.2.5 Qualitestrx (DAVA Pharmaceuticals) Recent Developments
- 8.3 Pfizer (Hospira)
- 8.3.1 Pfizer (Hospira) Company Information
- 8.3.2 Pfizer (Hospira) Business Overview
- 8.3.3 Pfizer (Hospira) Methotrexate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Pfizer (Hospira) Methotrexate Product Portfolio
- 8.3.5 Pfizer (Hospira) Recent Developments
- 8.4 Roxane Laboratories
- 8.4.1 Roxane Laboratories Company Information
- 8.4.2 Roxane Laboratories Business Overview
- 8.4.3 Roxane Laboratories Methotrexate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Roxane Laboratories Methotrexate Product Portfolio
- 8.4.5 Roxane Laboratories Recent Developments
- 8.5 Sine
- 8.5.1 Sine Company Information
- 8.5.2 Sine Business Overview
- 8.5.3 Sine Methotrexate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Sine Methotrexate Product Portfolio
- 8.5.5 Sine Recent Developments
- 8.6 Maoxiang
- 8.6.1 Maoxiang Company Information
- 8.6.2 Maoxiang Business Overview
- 8.6.3 Maoxiang Methotrexate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Maoxiang Methotrexate Product Portfolio
- 8.6.5 Maoxiang Recent Developments
- 8.7 LingNan Pharmaceutical
- 8.7.1 LingNan Pharmaceutical Company Information
- 8.7.2 LingNan Pharmaceutical Business Overview
- 8.7.3 LingNan Pharmaceutical Methotrexate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 LingNan Pharmaceutical Methotrexate Product Portfolio
- 8.7.5 LingNan Pharmaceutical Recent Developments
- 8.8 Powerdone
- 8.8.1 Powerdone Company Information
- 8.8.2 Powerdone Business Overview
- 8.8.3 Powerdone Methotrexate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Powerdone Methotrexate Product Portfolio
- 8.8.5 Powerdone Recent Developments
- 8.9 Huiyu
- 8.9.1 Huiyu Company Information
- 8.9.2 Huiyu Business Overview
- 8.9.3 Huiyu Methotrexate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Huiyu Methotrexate Product Portfolio
- 8.9.5 Huiyu Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Methotrexate Value Chain Analysis
- 9.1.1 Methotrexate Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Methotrexate Production Mode & Process
- 9.2 Methotrexate Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Methotrexate Distributors
- 9.2.3 Methotrexate Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst